Arbor Capital Management (Minnesota)’s Acorda Therapeutics ACOR Stock Holding History

Arbor Capital Management (Minnesota)’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.5M	Sell	490 -198	-29%	-$644K	0.79%	64
2016 Q1	$2.18M	Sell	688 -55	-7%	-$228K	0.69%	68
2015 Q4	$3.81M	Hold	743	–	–	0.86%	45
2015 Q3	$2.36M	Hold	743	–	–	0.53%	93
2015 Q2	$2.97M	Sell	743 -811	-52%	-$3.13M	0.56%	89
2015 Q1	$6.21M	Buy	1,554 +270	+21%	+$1.24M	0.74%	72
2014 Q4	$6.29M	Buy	+1,284	New	+$5.51M	0.8%	65

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Arbor Capital Management (Minnesota)'s ACOR Position: Q2 2016 in Review

Arbor Capital Management (Minnesota) reduced its Acorda Therapeutics (ACOR) stake by 29% in Q2 2016, selling an estimated $644K and leaving 490 shares worth $1.5M. The position accounts for 0.79% of the portfolio, ranked #64.

Arbor Capital Management (Minnesota) first reported a position in ACOR in Q4 2014 and has held it in 7 quarters since. The position peaked at $6.29M in Q4 2014. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2016.

Arbor Capital Management (Minnesota) held 490 shares of Acorda Therapeutics worth $1.5M as of Q2 2016.
Arbor Capital Management (Minnesota) sold 198 Acorda Therapeutics shares in Q2 2016, an estimated $644K.
Acorda Therapeutics made up 0.79% of Arbor Capital Management (Minnesota)'s portfolio in Q2 2016, its #64 holding.
Arbor Capital Management (Minnesota) first reported a position in Acorda Therapeutics in Q4 2014 and has held it in 7 quarters since.
Arbor Capital Management (Minnesota)'s Acorda Therapeutics position peaked at $6.29M in Q4 2014.
175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2016.

Based on Arbor Capital Management (Minnesota)'s 13F filing for Q2 2016, filed 15 Aug 2016.